| Catalog No. | HV466056 |
| Host species | Humanized |
| Species reactivity | Human |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG4-kappa |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target | SGRF, IL-23-A, IL-23 subunit alpha, Interleukin-23 subunit p19, IL23A, Interleukin-23 subunit alpha, IL-23p19 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | Mammalian Cells |
| Accession | Q9NPF7 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternative name | LY-3074828, 1884201-71-1 |
| Species | Human |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Research Grade Mirikizumab
Overview
Description
Research Grade Mirikizumab (HV466056) is a humanized monoclonal antibody detecting SGRF in ELISA, Bioactivity: FACS, Functional assay, Research in vivo. Suitable for Human.
Highlights
- ●Multi-Application — Validated across multiple applications.
Images
 Bioactivity |
Detects IL23A in indirect ELISAs. |
 SDS-PAGE |
SDS-PAGE for Research Grade Mirikizumab |
 Bioactivity |
Detects IL23A in indirect ELISA |